Pure Global AI
NCT06321107Recruiting

Long-term Follow-up Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference

A Phase II/III Extension Study Comparing the Long-term Safety of GenSci094 and Gonal-f® in Chinese ART Patients
Changchun GeneScience Pharmaceutical Co., Ltd.ClinicalTrials.gov
Verified
Study focus
Disease/Condition
Infertility
Study type
Observational
Sponsor & location
Primary sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Location
Guangzhou, China
Timeline & enrollment
Phase
N/A
Start date
Feb 29, 2024
End date
Oct 31, 2025
Enrollment
158 participants
Primary outcome

Summary of Pregnancy Outcome

Summary

The purpose of this study is to evaluate the safety of a single injection of GenSci094 during
 Controlled Ovarian Stimulation up to 1 year old of the infants from previous studies.

ICD-10 classifications
Female infertilityMale infertilityFemale infertility, unspecifiedFemale infertility of other originFemale infertility of uterine origin
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06321107
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06321107 through Pure Global AI's free database. This phase not specified trial is sponsored by Changchun GeneScience Pharmaceutical Co., Ltd. and is currently Recruiting. The study focuses on Infertility. Target enrollment is 158 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.